Dear Friends and Supporters,

Throughout my decades in medicine and healing, I’ve consistently observed that true, lasting health comes from restoring the body's innate balance by addressing root causes, not just symptoms. This principle has been the bedrock of my research into Galectin-3 and its profound impact on our survival response and overall wellbeing.

It’s deeply affirming to see the global sepsis research community now emphasizing what I’ve long believed in: the need for targeted therapies. The focus is shifting towards solutions that gently guide the body back to balance, rather than broadly altering its functions. This very principle is the heart of our XGal-3® approach.

Our strategy of selectively removing excess Galectin-3 to interrupt the destructive inflammatory cascade in sepsis directly applies these ideas. This alignment of global scientific direction with our long-held understanding gives me immense hope. With XGal-3®, we are contributing to a more profound, effective, and gentle way of healing.

Your belief in this vision helps bring us closer to making this a reality for so many!

With deep gratitude and hope,

Isaac Eliaz, MD, MS, LAc